pipette
ESEspañol

Dynamically adaptive soft bioelectronics for neuro-immunomodulatory cancer therapy

Wenliang Liu, Jingjie Liu, Renyuan Sun, Ming Yang, Dingke Zhang, Kun Yang, Weixian Xu, Chuan Gao, Shihao Wang, Ziyu Zhang, Qiong Wang, Wenyuan Wang, Qingya Liu, Lei Zhang, Jiexiong Feng, Xiangliang Yang, Lu Gan, Zhiqiang Luo

Peer-reviewed journalReal-world use

In the authors' words

Abstract Many solid tumors remain refractory to immunotherapy due to profoundly immunosuppressive tumor microenvironments. Although vagus nerve stimulation offers a direct neural axis to reprogram immune function, its potential in cancer immunotherapy remains unrealized due to the absence of stable, system-level neuromodulation platforms. Herein, we develop a miniature subdiaphragmatic vagus nerve stimulator (SVNS) for near-organ neuromodulation of pancreatic tumor immunity. To construct stable electrical coupling with subdiaphragmatic vagus nerve (SVN) along the esophagus, a dynamically adaptive neural interface comprising an injectable anti-fatigue adhesive conductive hydrogel and a deformable liquid metal electrode is explored. The SVNS is integrated with a battery-free lead-free wireless power module, which can be configured into a Swiss-roll architecture, enabling minimally invasive implantation. In an orthotopic mouse model of pancreatic tumor, chronic SVN stimulation using SVNS suppressed tumor growth and metastasis, reshaped tumor innervation, promoted a shift toward an M1-like TAM phenotype, enhanced cytotoxic immune cell infiltration, and further potentiated the efficacy of anti-PD-1 immunotherapy.

Main resultThe abstract does not state a limitation.

In plain words AI summary

Many solid tumors resist immunotherapy because their surroundings suppress the immune system. The authors built a tiny wireless device that stimulates the vagus nerve near the pancreas. The device uses a stretchy gel and liquid metal to maintain stable contact with the nerve. In mice with pancreatic tumors, chronic stimulation slowed tumor growth and spread. The treatment also increased immune cell infiltration and improved anti-PD-1 immunotherapy effectiveness.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Wednesday, October 28. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-79002-w